There is strong evidence that CXCL9 or CXCL10 and their receptor CXCR3 are required for the development of murine cerebral malaria (Belnoue et al., 2008; Campanella et al., 2008; Van den Steen et al., 2008; Miu et al., 2008a; Nie et al., 2009). Here, CXCL10 is linked to cerebral malaria.